PTAC/CFTR
Jane Davies, MD, MBChB, MRCP
National Heart and Lung Institute
Imperial College London
Claire Keating, MD
Columbia University Irving Medical Center
The purpose of this symposium is to provide up to date information on active and upcoming genetic therapy trials in persons with cystic fibrosis. This will review the important considerations in study design, conduct, and outcomes measures of the growing field of nucleotide based treatments
Speaker: George M. Solomon, M.D. – University of Alabama at Birmingham
Speaker: Jennifer L. Taylor-Cousar, MD – National Jewish Health
Speaker: Peter Wark, MBBS – University of Newcastle.
Speaker: Eric Alton – National Heart and Lung Institute, Imperial College London